Bryhali Topical Product
RxNorm 2101714

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2101714 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Bryhali Topical Product.

The following semantic concepts and normalized strings are associated with this clinical entity:

SBDG
Bryhali Topical Product
AUI:10774630
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDGPrescribable

Semantic Branded Dose Form Group (SBDG):
Bryhali Topical Product
(Atom ID: 10774630)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Bryhali Topical Product
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2101714
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
10774630
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBDG
Semantic Branded Dose Form Group (Brand Name + Dose Form Group)
Source Code
2101714
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AVAILABLE STRENGTH
0.1 MG/ML (expressed as halobetasol propionate)
Available drug strengths listed in the order of ingredients from the drug